1225 - Gene Editing/Gene Therapies: GDA-501 HER-2 CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELLS: DUAL CYTOTOXICITY IN SOLID TUMORS MEDIATED VIA HER2 AND TRAIL von Rifman, J., Berhani-Zipori, O., Yackoubov, D., Cohen, S., Brycman, N., Hailu, A., Edri, A., Simantov, R., Pato, A., Geffen, Y.

Volltext

Gene Editing/Gene Therapies: GDA-501 HER-2 CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELLS: DUAL CYTOTOXICITY IN SOLID TUMORS MEDIATED VIA HER2 AND TRAIL von Rifman, J., Berhani-Zipori, O., Yackoubov, D., Cohen, S., Brycman, N., Hailu, A., Edri, A., Simantov, R., Pato, A., Geffen, Y.

Volltext

Immunotherapy: GDA-601: NAM-NK CELLS WITH CD38 KNOCKOUT EXPRESSES ENHANCED CD38 CHIMERIC ANTIGEN RECEPTOR AND TARGETS MULTIPLE MYELOMA CELLS WITH INCREASED CYTOTOXICITY von Edri, A., Hailu, A., Haim, N. Ben, Brycman, N., Berhani-Zipori, O., Rifman, J., Cohen, S., Yackoubov, D., Simantov, R., Hendel, A., Pato, A., Geffen, Y.

Volltext

Immunotherapy: GDA-301: ENGINEERED NAM-NK CELLS VIA CISH KNOCKOUT AND MEMBRANE-BOUND IL-15 EXPRESSION INCREASES CYTOTOXICITY AGAINST MALIGNANCIES von Rifman, J., Haim, N. Ben, Cohen, S., Brycman, N., Hailu, A., Berhani-Zipori, O., Edri, A., Yackoubov, D., Simantov, R., Hendel, A., Pato, A., Geffen, Y.

Volltext